Clinical Trial Update: Safety & Efficacy of the Extracorporeal Liver Assist Device (ELAD) System in Patients With Hepatic Insufficiency [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports on the safety and efficacy outcomes of the Extracorporeal Liver Assist Device (ELAD) in patients with hepatic insufficiency, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Viral Hepatitis

Drugs mentioned

• ELAD (extracorporeal liver assist device)

Snippet

Sponsor: Vital Therapies, Inc. | Conditions: Acute Hepatitis, Chronic Hepatitis | Phase 1, Phase 2 | Status: COMPLETED